I dont think Pourhassan has painted himself into a

I dont think Pourhassan has painted himself into a corner.

Clearly he has some support from his board of directors. Clearly the CyDy board is doing little if not nothing to minimize erratic communications.

Probably the CYDY board is just as overwhelmed by the covid vortex that CYDy has gotten sucked into.

Partial success on CD12 may have cemented Pourhassan's position in the minds of the CYDY board.

Pourhassan only needs one hit to transition from goat to GOAT in the broader investment community.

Will the Phillipines make a purchase order?

Will Canada make a purchase order?

Will CD16 strike quickly?

The NASH trial reads out at week 14. 20 of 60 enrolled now.

Long hauler trial reads out at week 14 also? 100 fullly enrolled by end of March.

HIV BLA could go any which way.

Probably the key factor in the CYDY board assessment of Pourhassan is CYDY's financing situation.

Through Sept-oct-Nov-Dec the CYDY financial situation appeared dire, but Streeterville/Fife just kept right ahead financing them.

Now February is over, and half of March, and no SEC filing has been made to describe the monthly share delivery to Streeterville/Fife. So something concrete happened in February with Streeterville/Fife? No SEC filing means that Streeterville/Fife postponed their February share delivery for some other consideration?

During recent calls Pourhassan seemed unconcerned about cash.

If Pourhassan has the cash to get through all of the potential lightning strikes in 2021, then he is sitting pretty, I think.